David W. Dube
Presidente en Stock Car Stocks Mutual Fund, Inc. .
Cargos activos de David W. Dube
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| Stock Car Stocks Mutual Fund, Inc. | Presidente | 23/12/2009 | - |
Historial de carrera de David W. Dube
Antiguos cargos conocidos de David W. Dube.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CNE Group, Inc. | Director/Miembro de la Junta | - | 14/11/2005 |
| SWAN GROUP OF COMPANIES, INC. | Presidente | - | - |
| Director Financiero/CFO | - | - | |
Glycogenesys, Inc.
 Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Director/Miembro de la Junta | 01/05/1998 | - |
| Independent Dir/Board Member | 01/05/1998 | - |
Formación de David W. Dube.
| Bentley University | Graduate Degree |
| Suffolk University | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Director/Board Member | 2 |
| Graduate Degree | 2 |
| Independent Dir/Board Member | 1 |
Sectorial
| Commercial Services | 3 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
| CNE Group, Inc. | Commercial Services |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | Commercial Services |
| Stock Car Stocks Mutual Fund, Inc. | Miscellaneous |
Swan Group of Cos., Inc.
 Swan Group of Cos., Inc. Wholesale DistributorsDistribution Services Swan Group of Companies, Inc. engages in the manufacture and sale of smokeless cigarette products. The company was founded on January 24, 1996 and is headquartered in Largo, FL. | Distribution Services |
- Bolsa de valores
- Insiders
- David W. Dube
- Experiencia
